Search for: "Alphapharm Pty. Ltd."
Results 21 - 40
of 49
Sorted by Relevance
|
Sort by Date
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
7 May 2012, 10:51 am
Alphapharm Pty., Ltd., 492 F.3d 1350 (Fed. [read post]
18 Jan 2010, 6:30 am
Rather, in order to be citable, a prior art reference must firstly be shown to be a piece of prior art information that the skilled person could have been reasonably expected to have “ascertained, understood, and regarded as relevant”.Secondly, since the landmark High Court decision in Aktiebolaget Hassle v Alphapharm Pty Ltd [2002] HCA 59, “obvious to try” does not make an invention obvious in Australia. [read post]
15 Sep 2011, 5:46 am
The other defendants are sister companies, Alphapharm PTY Ltd. of Australia and Canada's Genpharm ULC, both accused of helping to run the scheme and manufacture or procure the medicines. [read post]
21 Jan 2010, 6:32 pm
Secondly, since the landmark High Court decision in Aktiebolaget Hassle v Alphapharm Pty Ltd [2002] HCA 59, “obvious to try” does not make an invention obvious in Australia. [read post]
9 Jul 2007, 3:49 am
Alphapharm PTY., LTD., et al. (06/28/2007): appeal of decision that patent-in-suit was not invalid for obviousness (affirmed); discussion of patent related to antidiabetic compounds (U.S. [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Lexapro (Escitalopram) - Australia: High Court refuses special leave concerning enantiomer patents HLundbeck A/S v Alphapharm Pty Ltd (IP Whiteboard) LoSeasonique (Ethinyl Estradiol) –Infringement of US Patent following a Paragraph IV certification: Teva Women's Health, Inc. v. [read post]
14 Jul 2010, 6:47 pm
Glaxo tries a ‘Linux’ (Spicy IP) TB Alliance and DNDi team up to fight neglected diseases (IP Watch) Australia: Pharmaceuticals extensions and international inequities: H Lundbeck A/S v Alphapharm Pty Ltd, Ortho-McNeil Pharmaceutical, Inc v Lupin Pharmaceuticals, Inc (Patentology) Australia: The ‘morality’ of gene patents (Patentology) Belgium: Antwerp commercial court finds Belgian counterpart of EU patent covering process for producing L-Lysine by… [read post]
9 Sep 2011, 6:13 am
They are Alphapharm Pty Ltd. in Australia and Genpharm ULC in Canada. [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Escitalopram – Australia: Patent office grants 121 month extension of time: Alphapharm Pty Ltd & Ors v H. [read post]
22 Jul 2008, 7:51 pm
Alphapharm Pty., Ltd., 492 F.3d 1350, 1356 (Fed. [read post]
24 Mar 2010, 4:45 am
Alphapharm Pty Ltd. et al. [read post]
13 May 2009, 11:44 pm
Alphapharm Pty., Ltd., 492 F.3d 1350, 1357 (Fed. [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US: District Court of New Jersey… [read post]
9 Sep 2010, 7:09 pm
Alphapharm Pty., Ltd., 492 F.3d 1350, 1356 (Fed. [read post]
24 Sep 2010, 1:15 pm
Alphapharm Pty., Ltd., 492 F.3d 1350 (Fed. [read post]
2 Sep 2010, 10:51 am
Alphapharm Pty., Ltd., 492 F.3d 1350 (Fed. [read post]
4 Sep 2012, 7:38 am
Alphapharm Pty., Ltd., 492 F.d 1350, 1357 (Fed. [read post]
25 Jul 2008, 2:11 am
Alphapharm Pty., Ltd., 492 F.3d 1350, 1356 (Fed. [read post]
15 Feb 2013, 9:29 am
Alphapharm Pty., Ltd., 492 F.3d 1350, 1357 (Fed. [read post]
